We are live on ! Find out more
FURX

FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX

Delisted

FURX was delisted on the 1st of July, 2014.

114 hedge funds and large institutions have $565M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 26 increasing their positions, 39 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

457% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 7

116% more capital invested

Capital invested by funds: $261M → $565M (+$304M)

61% more call options, than puts

Call options by funds: $42M | Put options by funds: $26M

36% more funds holding

Funds holding: 84114 (+30)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

33% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 39

Holders
114
Holders Change
+30
Holders Change %
+35.71%
% of All Funds
3.29%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
39
Increased
26
Reduced
39
Closed
7
Calls
$42M
Puts
$26M
Net Calls
+$16M
Net Calls Change
+$15M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$4.56M +$561K +7,269 +16%
FSA
27
Franklin Street Advisors
North Carolina
$4.27M -$252K -3,270 -6%
ACM
28
American Capital Management
New York
$4.24M -$29.6K -384 -0.8%
BCM
29
Breithorn Capital Management
New York
$3.74M -$394K -5,100 -11%
BBA
30
Baker Bros. Advisors
New York
$3.51M +$3.11M +40,309 New
KCM
31
Kingdon Capital Management
New York
$3.48M +$3.09M +40,017 New
JP Morgan Chase
32
JP Morgan Chase
New York
$3.48M -$959K -12,417 -24%
Macquarie Group
33
Macquarie Group
Australia
$3.22M +$2.86M +37,000 New
HI
34
HBK Investments
Texas
$3.19M +$2.83M +36,682 New
AQR Capital Management
35
AQR Capital Management
Connecticut
$3.08M +$1.74M +22,600 +176%
TAM
36
Tocqueville Asset Management
New York
$2.92M +$355K +4,600 +16%
VAM
37
Visium Asset Management
New York
$2.82M -$21.6M -280,294 -90%
TI
38
Turner Investments
Pennsylvania
$2.75M -$3.8M -49,241 -61%
BIM
39
Bogle Investment Management
Massachusetts
$2.57M +$2.28M +29,589 New
GTC
40
Ghost Tree Capital
New York
$2.39M +$2.12M +27,500 New
TCIM
41
TIAA CREF Investment Management
New York
$2.39M -$102K -1,320 -5%
BA
42
BlackRock Advisors
Delaware
$2.38M +$1.74M +22,570 +469%
SBH
43
Segall Bryant & Hamill
Illinois
$2.26M -$15.1K -196 -0.7%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$2.04M
Charles Schwab
45
Charles Schwab
California
$1.84M +$130K +1,680 +9%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$1.83M -$31.1K -403 -2%
HAMF
47
Hatteras Alternative Mutual Funds
North Carolina
$1.79M +$1.59M +20,558 New
Marshall Wace
48
Marshall Wace
United Kingdom
$1.79M +$1.59M +20,537 New
BIA
49
Biondo Investment Advisors
Pennsylvania
$1.71M +$1.52M +19,625 New
Deutsche Bank
50
Deutsche Bank
Germany
$1.68M -$57.6K -746 -4%

FURX Hedge Fund Activity: Q1 2014 in Review

114 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q1 2014, worth a combined $565M — up 116% from $261M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new FURX positions and 7 closed out — a net gain of 32 holders — while 26 added to existing stakes and 39 trimmed.

The largest buyer was Millennium Management, adding an estimated $24.6M. The largest seller was Visium Asset Management, cutting an estimated $21.6M.

  • 114 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q1 2014, up from 84 in Q4 2013.
  • Funds reported $565M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014, up 116% quarter-over-quarter.
  • 39 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 7 closed out, a net change of +32 holders.
  • The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Millennium Management, an estimated $24.6M added.
  • The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2014 was Visium Asset Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q1 2014.